Meningitic Escherichia coli α-hemolysin aggravates blood-brain barrier disruption via targeting TGFβ1-triggered hedgehog signaling

Mol Brain. 2021 Jul 19;14(1):116. doi: 10.1186/s13041-021-00826-2.

Abstract

Bacterial meningitis is a life-threatening infectious disease with severe neurological sequelae and a high mortality rate, in which Escherichia coli is one of the primary Gram-negative etiological bacteria. Meningitic E. coli infection is often accompanied by an elevated blood-brain barrier (BBB) permeability. BBB is the structural and functional barrier composed of brain microvascular endothelial cells (BMECs), astrocytes, and pericytes, and we have previously shown that astrocytes-derived TGFβ1 physiologically maintained the BBB permeability by triggering a non-canonical hedgehog signaling in brain microvascular endothelial cells (BMECs). Here, we subsequently demonstrated that meningitic E. coli infection could subvert this intercellular communication within BBB by attenuating TGFBRII/Gli2-mediated such signaling. By high-throughput screening, we identified E. coli α-hemolysin as the critical determinant responsible for this attenuation through Sp1-dependent TGFBRII reduction and triggering Ca2+ influx and protein kinase A activation, thus leading to Gli2 suppression. Additionally, the exogenous hedgehog agonist SAG exhibited promising protection against the infection-caused BBB dysfunction. Our work revealed a hedgehog-targeted pathogenic mechanism during meningitic E. coli-caused BBB disruption and suggested that activating hedgehog signaling within BBB could be a potential protective strategy for future therapy of bacterial meningitis.

Keywords: Blood–brain barrier; Escherichia coli; Hedgehog signaling; Intercellular communication; TGFβ1; α-Hemolysin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism
  • Astrocytes / pathology
  • Blood-Brain Barrier / microbiology*
  • Blood-Brain Barrier / pathology*
  • Brain / blood supply
  • Calcium / metabolism
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cyclohexylamines / pharmacology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelium / pathology
  • Enzyme Activation
  • Escherichia coli / pathogenicity
  • Escherichia coli Proteins / metabolism*
  • Female
  • HEK293 Cells
  • Hedgehog Proteins / metabolism*
  • Hemolysin Proteins / metabolism*
  • Humans
  • Meningitis, Bacterial / microbiology*
  • Meningitis, Bacterial / pathology*
  • Mice
  • Microvessels / pathology
  • Models, Biological
  • Nuclear Proteins / metabolism
  • Promoter Regions, Genetic / genetics
  • Receptor, Transforming Growth Factor-beta Type II / metabolism
  • Signal Transduction* / drug effects
  • Thiophenes / pharmacology
  • Transforming Growth Factor beta1 / metabolism*
  • Zinc Finger Protein Gli2 / metabolism
  • Zonula Occludens-1 Protein / metabolism

Substances

  • Cyclohexylamines
  • Escherichia coli Proteins
  • GLI2 protein, human
  • Hedgehog Proteins
  • Hemolysin Proteins
  • Hlya protein, E coli
  • Nuclear Proteins
  • SAG compound
  • TJP1 protein, human
  • Thiophenes
  • Transforming Growth Factor beta1
  • Zinc Finger Protein Gli2
  • Zonula Occludens-1 Protein
  • Cyclic AMP-Dependent Protein Kinases
  • Receptor, Transforming Growth Factor-beta Type II
  • Calcium